Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
Anacor Pharmaceuticals, Inc. (ANAC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/24/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/24/2016 |
4
| Shapiro Lucy (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 06/24/2016 |
4
| RIEFLIN WILLIAM JL (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 89,000 shares
@ $99.25, valued at
$8.8M
Disposed/sold 853 shares
@ $99.25, valued at
$84.7k
Disposed/sold 4,403 options to buy
@ $69.4, valued at
$305.6k
|
|
| 06/24/2016 |
4
| LESCHLY MARK (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 794 shares
@ $99.25, valued at
$78.8k
Disposed/sold 30,000 options to buy
@ $6.92, valued at
$207.6k
Disposed/sold 24,000 options to buy
@ $6.74, valued at
$161.8k
Disposed/sold 15,000 options to buy
@ $5.2, valued at
$78k
Disposed/sold 15,000 options to buy
@ $5.11, valued at
$76.7k
Disposed/sold 15,000 options to buy
@ $14.22, valued at
$213.3k
Disposed/sold 4,096 options to buy
@ $69.4, valued at
$284.3k
|
|
| 06/24/2016 |
4
| Leonard Keith R (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 06/24/2016 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 794 shares
@ $99.25, valued at
$78.8k
Disposed/sold 27,000 options to buy
@ $25.48, valued at
$688k
Disposed/sold 4,096 options to buy
@ $69.4, valued at
$284.3k
|
|
| 06/24/2016 |
4
| Zane Lee (SVP and Chief Medical Officer) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 06/24/2016 |
4
| Bell Graeme (Executive VP and CFO) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 06/24/2016 |
4
| BERNS PAUL L (President and CEO) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 06/24/2016 |
4
| Sullivan Ryan T (EVP and General Counsel) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 06/24/2016 |
4
| IPPOLITO VINCENT P (EVP & Chief Commercial Officer) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 06/03/2016 |
4
| Bell Graeme (Executive VP and CFO) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 05/24/2016 |
4
| Leonard Keith R (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 05/18/2016 |
4
| Hove Anders D (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 04/29/2016 |
4
| Sullivan Ryan T (EVP and General Counsel) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 04/15/2016 |
4
| Hove Anders D (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 04/11/2016 |
4
| Hove Anders D (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 04/04/2016 |
4
| RIEFLIN WILLIAM JL (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Exercised 30,000 shares
@ $6.92, valued at
$207.6k
Exercised 7,500 shares
@ $6.74, valued at
$50.6k
Exercised 12,500 shares
@ $5.2, valued at
$65k
Exercised 15,000 shares
@ $5.11, valued at
$76.7k
Exercised 24,000 shares
@ $14.22, valued at
$341.3k
Exercised 30,000 options to buy
@ $6.92, valued at
$207.6k
Exercised 7,500 options to buy
@ $6.74, valued at
$50.6k
Exercised 12,500 options to buy
@ $5.2, valued at
$65k
Exercised 15,000 options to buy
@ $5.11, valued at
$76.7k
Exercised 24,000 options to buy
@ $14.22, valued at
$341.3k
|
|
| 03/22/2016 |
4
| BERNS PAUL L (President and CEO) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Sold 9,700 shares
@ $59.8903, valued at
$580.9k
Sold 27,800 shares
@ $60.4561, valued at
$1.7M
|
|
| 03/04/2016 |
4
| IPPOLITO VINCENT P (EVP & Chief Commercial Officer) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 02/05/2016 |
4
| Zane Lee (SVP and Chief Medical Officer) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Granted 4,375 shares
@ $0
Granted 22,136 options to buy
@ $78.91, valued at
$1.7M
Granted 4,375 options to buy
@ $0 |
|
| 02/05/2016 |
4
| IPPOLITO VINCENT P (EVP & Chief Commercial Officer) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 25,299 options to buy
@ $78.91, valued at
$2M
Granted 5,000 options to buy
@ $0 |
|
| 02/05/2016 |
4
| Sullivan Ryan T (EVP and General Counsel) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Granted 6,250 shares
@ $0
Granted 31,623 options to buy
@ $78.91, valued at
$2.5M
Granted 6,250 options to buy
@ $0 |
|
| 02/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/05/2016 |
4
| Bell Graeme (Executive VP and CFO) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 11/08/2013 |
4
| Zane Lee (SVP and Chief Medical Officer) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 11/08/2013 |
4
| Chanda Sanjay (SVP, Drug Development) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 10/04/2013 |
4
| Parker Geoffrey M. (Senior Vice President and CFO) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 08/14/2013 |
4
| Maples Kirk R (SVP, Program Management) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 08/13/2013 |
4
| Parker Geoffrey M. (Senior Vice President and CFO) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 06/19/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/18/2013 |
4
| Parker Geoffrey M. (Senior Vice President and CFO) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 06/10/2013 |
4
| Hove Anders D (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
| 06/07/2013 |
4
| KLINGENSTEIN PAUL H (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc. |
|
|
|